KIRBY WILLIAMS: Open Payments
NPI 1700154879 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,301 in 28 payments from 8 companies in 2025. Trend: 2023 $2,876 · 2024 $19,761 · 2025 $12,301
Speaker / faculty: $6,117Consulting: $3,330Food & beverage: $1,531Travel & lodging: $1,323
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $6,298 |
| Teva Pharmaceuticals USA, Inc. | 5 | $4,436 |
| Alkermes, Inc. | 2 | $756 |
| E.R. Squibb & Sons, L.L.C. | 3 | $301 |
| ABBVIE INC. | 4 | $281 |
| Neurocrine BioSciences, Inc. | 1 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $92 |
| Indivior Inc. | 2 | $45 |
Products named: REXULTI, ARISTADA, COBENFY, VRAYLAR, INGREZZA, CAPLYTA, SUBLOCADE.
Industry payments across VA — which companies pay providers there.
